Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: NEOPLASIAS DO CÓRTEX SUPRARRENAL, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, Carlos Alberto et al. AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2014APA
Scrideli, C. A., Borges, K. S., Andrade, A. F., Silveira, V. S., Antonio, D. A. M., Vasconcelos, E. J. R., et al. (2014). AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Scrideli CA, Borges KS, Andrade AF, Silveira VS, Antonio DAM, Vasconcelos EJR, Antonini SRR, Martinelli Junior CE, Castro M de, Tone LG. AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line. Pediatric Blood and Cancer. 2014 ; 61 S371.[citado 2024 out. 31 ]Vancouver
Scrideli CA, Borges KS, Andrade AF, Silveira VS, Antonio DAM, Vasconcelos EJR, Antonini SRR, Martinelli Junior CE, Castro M de, Tone LG. AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line. Pediatric Blood and Cancer. 2014 ; 61 S371.[citado 2024 out. 31 ]
